Targeting Matrix Metalloproteinases and Their Inhibitors in Melanoma
Author Information
Author(s): Szczygielski Orest, Dąbrowska Emilia, Niemyjska Sylwia, Przylipiak Andrzej, Zajkowska Monika
Primary Institution: Medical University of Białystok, Poland
Hypothesis
The review aims to present the current knowledge of the role of matrix metalloproteinases in the development of melanoma and their potential use as therapeutic targets.
Conclusion
Matrix metalloproteinases (MMPs) play a critical role in melanoma progression and are potential therapeutic targets.
Supporting Evidence
- MMPs are involved in the degradation of the extracellular matrix, which is crucial for tumor progression.
- High levels of MMP expression are associated with poor prognosis in melanoma patients.
- Inhibiting MMP activity may prevent tumor growth and metastasis.
- Clinical trials have tested various MMP inhibitors, but challenges remain in their development.
- MMPs can influence immune responses, potentially affecting treatment outcomes.
Takeaway
MMPs are important proteins that help melanoma grow and spread, and finding ways to block them could help treat this type of skin cancer.
Methodology
This is a review article summarizing existing knowledge and research on MMPs in melanoma.
Limitations
The review discusses the limitations of current MMP inhibitors and the challenges in developing effective therapies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website